Gram-negative Bacteremia: Clinical Trials

7 trials for Gram-negative Bacteremia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 1 not yet recruiting, 1 withdrawn. 7 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable7Completed 3, Recruiting 2, Not yet recruiting 1, Withdrawn 1

Follow Gram-negative Bacteremia: new trials by email Literature Review of Gram-negative Bacteremia trials Research Report on Gram-negative Bacteremia

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Real-time MIC (Minimum Inhibitory Concentration) Reporting (<6 Hours) on β-lactam Prescription in Cases of Gram-negative Bacilli Bacteremia in ICU Patients in Real-life Settings
SPECIFIC REVEAL® Rapid AST system, antibiotic susceptibility testing on agar medium - Gram-negative Bacteremia, Intensive Care Patients
Not applicableNot yet recruitingAssistance Publique - Hôpitaux de Paris2002025-10-012025-10-01
A Platform Trial for Gram Negative Bloodstream Infections
De-escalation VS No De-escalation, Oral beta-lactams VS non beta-lactams, Central vascular catheter retention VS Central vascular catheter replacement - Gram-negative Bacteremia
Not applicableRecruitingSunnybrook Health Sciences Centre25002024-04-242026-09-04
Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial
Intravenous Antibiotics, Oral Antibiotics - Gram-negative Bacteremia
Not applicableRecruitingJohns Hopkins University10302024-02-222026-03-11
Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial
Reveal - Gram-negative Bacteremia, Bloodstream Infection
Not applicableCompletedDuke University8992023-12-222026-07-28
BALANCE+ Vanguard Phase
De-escalation VS No De-escalation, Oral beta-lactams VS non beta-lactams, Central vascular catheter retention VS Central vascular catheter replacement - Gram-negative Bacteremia
Not applicableCompletedSunnybrook Health Sciences Centre1742023-08-262024-10-01
Clinical Impact of Fast Phenotypic Antimicrobial Susceptibility Testing on Patients With Gram-Negative Rod Bacteremia
Accelerate Pheno, Standard of Care - Gram-negative Bacteremia
Not applicableWithdrawnAccelerate Diagnostics, Inc.2019-09-302020-04-14
Rapid Identification and Phenotypic Susceptibility Testing for Gram-Negative Bacteremia
Accelerate PhenoTest™ BC Kit, Standard Culture and AST - Gram-negative Bacteremia
Not applicableCompletedDuke University5002017-10-092019-11-26

Narrower conditions

Critical Illness (1)  ·  Escherichia coli Infections (1)  ·  Pseudomonas Infections (1)  ·  Sepsis (1)

Broader conditions

Infections (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Disease Attributes (1)  ·  Enterobacteriaceae Infections (1)  ·  Gram-Negative Bacterial Infections (1)  ·  Inflammation (1)  ·  Systemic Inflammatory Response Syndrome (1)

Interventions

Anti-Bacterial Agents (1)

Sponsors

Duke University (2)  ·  Sunnybrook Health Sciences Centre (2)  ·  Accelerate Diagnostics, Inc. (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Johns Hopkins University (1)

Countries

Canada (2)  ·  Israel (2)  ·  United States (2)  ·  Australia (1)  ·  Colombia (1)  ·  Greece (1)  ·  India (1)  ·  New Zealand (1)  ·  Spain (1)

Top investigators

Nick Daneman, MD (2)  ·  Ritu Banerjee, MD, PhD (2)  ·  Rob Fowler, MD (2)  ·  Pranita D Tamma, MD, MHS (1)  ·  Sara E Cosgrove, MD, MS (1)  ·  Vance Fowler, MD (1)

Results publications

PMID 32374822, PMID 41225518, PMID 41360461, PMID 41999287

NIH funding

5UM1AI104681 (1), UM1AI104681 (1)